Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Larson

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 16, 2017
Patient and Physician Perceptions of Genetic Testing in Primary CareSamuel A Evenson, H Eugene Hoyme, Jan E Haugen-Rogers, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|March 9, 2023
Cytochrome P450 2D6 Genotyping for Post-Operative OpioidsJacob Thomsen, Russell A Wilke, Matthew Jahraus, et al.
Clinical Pharmacology and Therapeutics|May 8, 2023
Drug-Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research ProgramShaopeng Gu, Govarthanan Rajendiran, Kennedy Forest, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine CareDeepak Voora, Jordan Baye, Adam McDermaid, et al.
International Journal of General Medicine|June 29, 2016
Decreasing the critical value of hemoglobin required for physician notification reduces the rate of blood transfusionsEric A Larson, Paul A Thompson, Zachary K Anderson, et al.
Pharmacogenomics|April 16, 2019
<i>CYP2C19</i> genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitorsNatasha Petry, Roxana Lupu, Ahmed Gohar, et al.
Pharmacogenomics|May 26, 2023
<i>SLCO1B1</i> gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatinAmanda Massmann, Joel Van Heukelom, Robert C Green, et al.
Journal of the American Medical Informatics Association : JAMIA|March 13, 2021
DDIWAS: High-throughput electronic health record-based screening of drug-drug interactionsPatrick Wu, Scott D Nelson, Juan Zhao, et al.
Clinical Pharmacology and Therapeutics|November 14, 2024
Hyponatremia Associated with the Use of Common Antidepressants in the All of Us Research ProgramHuan Mo, Yamna Channa, Tracey M Ferrara, et al.
Clinical Pharmacology and Therapeutics|February 13, 2022
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal SymptomsRhonda M Cooper-DeHoff, Mikko Niemi, Laura B Ramsey, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
South Dakota Medicine : the Journal of the South Dakota State Medical Association|August 16, 2017
Patient and Physician Perceptions of Genetic Testing in Primary CareSamuel A Evenson, H Eugene Hoyme, Jan E Haugen-Rogers, et al.
South Dakota Medicine : the Journal of the South Dakota State Medical Association|March 9, 2023
Cytochrome P450 2D6 Genotyping for Post-Operative OpioidsJacob Thomsen, Russell A Wilke, Matthew Jahraus, et al.
Clinical Pharmacology and Therapeutics|May 8, 2023
Drug-Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research ProgramShaopeng Gu, Govarthanan Rajendiran, Kennedy Forest, et al.
Clinical Pharmacology and Therapeutics|January 16, 2022
SLCO1B1*5 Allele Is Associated With Atorvastatin Discontinuation and Adverse Muscle Symptoms in the Context of Routine CareDeepak Voora, Jordan Baye, Adam McDermaid, et al.
International Journal of General Medicine|June 29, 2016
Decreasing the critical value of hemoglobin required for physician notification reduces the rate of blood transfusionsEric A Larson, Paul A Thompson, Zachary K Anderson, et al.
Pharmacogenomics|April 16, 2019
<i>CYP2C19</i> genotype, physician prescribing pattern, and risk for long QT on serotonin selective reuptake inhibitorsNatasha Petry, Roxana Lupu, Ahmed Gohar, et al.
Pharmacogenomics|May 26, 2023
<i>SLCO1B1</i> gene-based clinical decision support reduces statin-associated muscle symptoms risk with simvastatinAmanda Massmann, Joel Van Heukelom, Robert C Green, et al.
Journal of the American Medical Informatics Association : JAMIA|March 13, 2021
DDIWAS: High-throughput electronic health record-based screening of drug-drug interactionsPatrick Wu, Scott D Nelson, Juan Zhao, et al.
Clinical Pharmacology and Therapeutics|November 14, 2024
Hyponatremia Associated with the Use of Common Antidepressants in the All of Us Research ProgramHuan Mo, Yamna Channa, Tracey M Ferrara, et al.
Clinical Pharmacology and Therapeutics|February 13, 2022
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1, ABCG2, and CYP2C9 genotypes and Statin-Associated Musculoskeletal SymptomsRhonda M Cooper-DeHoff, Mikko Niemi, Laura B Ramsey, et al.
Pageof 3